SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

N.J. Assemblyman rejects parents' plea for more say on kids' vaccinations

By Leave a Comment

HJ.com
Published: Tuesday, March 08, 2011, 6:10 AM Updated: Tuesday, March 08, 2011, 9:16 AM

By Matt Friedman/Statehouse Bureau

TRENTON — The impassioned debate went on for more than an hour — despite witnesses being limited to only 90 seconds per statement.

But a bill that would allow parents to claim a conscientious objection from having their children vaccinated was firmly shot down Monday by the chairman of the Assembly Health and Senior Services Committee, who called it a “recipe for disaster.”

The debate marked the first time in seven years the controversial proposal was put up for formal discussion in the Assembly, and had appeared for a time to be gaining some momentum.

Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017

By Leave a Comment

Reportlinker Adds Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017

NEW YORK, March 9, 2011 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:

Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017

http://www.reportlinker.com/p0312154/Cancer-Vaccines—Pipeline-Assessment-and-Market-Forecasts-to-2017.html

Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global Cancer vaccines market. The report identifies key trends shaping and driving the global Atopic dermatitis disease market. It also provides insight on the prevalent competitive landscape and the emerging players expected to bring a significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Cancer vaccines sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research, and in house analysis by GlobalData’s team of industry experts.

Determination of Regulatory Review Period for Purposes of Patent Extension; CERVARIX

By Leave a Comment

Federal Register A Notice by the Food and Drug Administration on 03/09/2011 Summary The Food and Drug Administration (FDA) has determined the regulatory review period for CERVARIX and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of […]

The Difference: Bruesewitz v Berkovitz by F. Edward Yazbak, MD, FAAP

By Leave a Comment

Vaccinationnews The Difference Bruesewitz v Berkovitz 22 years Different Decisions Different US Supreme Courts Different Press and Public Opinions The United States Supreme Court recent decision in Bruesewitz V. Wyeth did not only affect a family. It affected thousands, who after unsuccessfully pursuing a claim through the National Vaccine Injury Compensation Program, will no longer […]

Pneumonia Vaccine Approved as Deaths Mount During Trial

By Leave a Comment

Gaia Health The vaccine trial is ongoing in Argentina. Parents agreed under threats of losing their children and without informed consent. GSK says it’s not the vaccine—but where’s the proof? by Heidi Stevenson 6 March 2011 As deaths were mounting from GlaxoSmithKline’s ongoing vaccine study in Argentina, the European Union’s Medicine Agency, EMEA, approved it […]

News

Videos

Contact